Binding and interstitial penetration of liposomes within avascular tumor spheroids

International Journal of Cancer. Journal International Du Cancer
Kostas KostarelosGeorge Sgouros

Abstract

The liposomal delivery of cancer therapeutics, including gene therapy vectors, is an area of intense study. Poor penetration of liposomes into interstitial tumor spaces remains a problem, however. In this work, the penetration of different liposomal formulations into prostate carcinoma spheroids was examined. Spheroid penetration was assessed by confocal microscopy of fluorescently labeled liposomes. The impact of liposomal surface charge, mean diameter, lipid bilayer fluidity and fusogenicity on spheroid penetration was examined. A variety of different liposome systems relevant to clinical or preclinical protocols have been studied, including classical zwitterionic (DMPC:chol) and sterically stabilized liposomes (DMPC:chol:DOPE-PEG2000), both used clinically, and cationic liposomes (DMPC:DOPE:DC-chol and DOTAP), forming the basis of the vast majority of nonviral gene transfer vectors tested in various cancer trials. Surface interactions between strongly cationic vesicles and the tumor cells led to an electrostatically derived binding-site barrier effect, inhibiting further association of the delivery systems with the tumor spheroids (DMPC:DC-chol). However, inclusion of the fusogenic lipid DOPE and use of a cationic lipid of l...Continue Reading

Citations

Sep 23, 2009·Cancer Chemotherapy and Pharmacology·Jose PradosAntonia Aránega
Oct 25, 2007·Journal of Fluorescence·Heather A D PerryAlain Pluen
Sep 16, 2008·Bioconjugate Chemistry·Thomas Tyrel GoodmanSuzie Hwang Pun
Jan 25, 2013·Journal of Virology·Raghunath ShobanaSubbiah Elankumaran
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jyotsnabaran HalderAnil K Sood
Nov 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cecilie B RyghKatherine W Ferrara
Mar 21, 2012·Critical Reviews in Biomedical Engineering·Carolyn L Waite, Charles M Roth
Mar 13, 2014·Molecular Therapy. Nucleic Acids·Kyle CarverRudolph L Juliano
Feb 21, 2014·Nanomedicine·Bingbing WangPhilip S Low
Sep 16, 2014·Journal of Pharmaceutical Innovation·Yi Wen, Wilson S Meng
Jul 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael G WientjesJessie L S Au
Sep 23, 2014·Nucleic Acid Therapeutics·Kyle CarverRudy L Juliano
Jul 12, 2013·BioMed Research International·Jong-Min LeeYoung-Seok Cho
Sep 5, 2012·Expert Review of Clinical Pharmacology·Hafiz Muhammad AliLiliane Massaad-Massade
Feb 6, 2008·Expert Opinion on Drug Delivery·Stavroula Sofou, George Sgouros
Dec 7, 2007·International Journal of Radiation Biology·Juergen FriedrichLeoni A Kunz-Schughart
Jan 18, 2008·Journal of Pharmaceutical Sciences·Ales Prokop, Jeffrey M Davidson
May 23, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Geeta MehtaShuichi Takayama
May 31, 2011·Colloids and Surfaces. B, Biointerfaces·Keita HayashiHiroshi Umakoshi
Jul 5, 2011·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ana R RamaA Aranega
Jul 6, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Wei TianWan-Liang Lu
Feb 12, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Itzik CooperYael Mardor
Jan 6, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·William Thomas PhillipsAnde Bao
Jun 30, 2006·The Journal of Gene Medicine·H R MellorR Callaghan
Jul 15, 2011·Biotechnology and Bioengineering·Carolyn L Waite, Charles M Roth
Mar 12, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yi ZhaoAlexander V Kabanov
May 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tian-Yuan ZhangJian-Qing Gao
Sep 16, 2009·Biophysical Journal·Oliver LielegAndreas R Bausch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.